BHC

BHC

USD

Bausch Health Companies Inc. Common Stock

$6.855-0.025 (-0.363%)

Real-time Price

Healthcare
Drug Manufacturers - Specialty & Generic
Canada

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$6.880

High

$6.940

Low

$6.781

Volume

2.33M

Company Fundamentals

Market Cap

2.5B

Industry

Drug Manufacturers - Specialty & Generic

Country

Canada

Trading Stats

Avg Volume

2.49M

Exchange

NYQ

Currency

USD

52-Week Range

Low $3.96Current $6.855High $9.85

Related News

AccessWire

Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence

Focused on highlighting real patient experiences, Salix continues to lead the charge in educating and advocating for the hepatic encephalopathy community LAVAL, QC / ACCESS Newswire / July 7, 2025 / Bausch Health

View more
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
AccessWire

Bausch Health to Announce Second Quarter 2025 Results on July 30

LAVAL, QC / ACCESS Newswire / July 2, 2025 / Bausch Health Companies Inc. will release second quarter 2025 financial results after market close on Wednesday, July 30, 2025. Bausch Health will host a

View more
Bausch Health to Announce Second Quarter 2025 Results on July 30